CACYBP and colonic neoplasm: Our group has generated a monoclonal antibody against CacyBP/SIP [6] and, using this specific antibody and immunohistochemistry, has shown that CacyBP/SIP is over-expressed in colon cancer tissue and is mainly localized in the nucleus [7].